Functional Electrical Stimulation Cycling for Managing Mobility Disability in People with Multiple Sclerosis
1 other identifier
interventional
10
1 country
1
Brief Summary
Mobility impairment is one of the most common, poorly managed, and life altering consequences of MS. Current therapies for managing MS do not prevent the long-term accumulation of mobility impairment, highlighting the need for alternative strategies that prevent or slow progressive mobility disability. The proposed trial will test the efficacy and lasting effects of functional electrical stimulation (FES) cycling as an exercise-based rehabilitation strategy for managing mobility impairment and associated consequences in MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Oct 2019
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 14, 2019
CompletedStudy Start
First participant enrolled
October 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2024
CompletedDecember 24, 2024
December 1, 2024
5 years
May 6, 2019
December 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Walking Speed
Walking speed will be assessed using the timed 25-foot walk (T25FW) test. Participants will walk as quickly and safely as possible across a 25-foot distance (2 trials; average reported in m/s).
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Secondary Outcomes (11)
Change in Walking Endurance
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Agility
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Patient-rated Mobility Impairment
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Cognitive Performance: Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Cognitive Performance: Paced Auditory Serial Addition Test (PASAT)
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
- +6 more secondary outcomes
Other Outcomes (4)
Change in Cardiorespiratory Fitness
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Muscular Fitness
Baseline, 12 weeks (mid-point), 24 weeks (immediately post intervention), and 36 weeks (12 weeks follow-up)
Change in Body Composition
Baseline and 24 weeks
- +1 more other outcomes
Study Arms (2)
FES Cycling Exercise
EXPERIMENTALFES cycling will involve systematic, transcutaneous electrical stimulation of the leg muscles to produce leg-cycling movement. The intensity and duration of training will be prescribed based on guidelines for aerobic exercise training for persons with MS and from the American College of Sports Medicine, and will progressively increase across 24 weeks. Participants will be encouraged to actively cycle at a minimum cadence of \~40-50 rpm, at 40-60% VO2peak for between 10-50 minutes. The intensity of stimulation will be adjusted per leg muscle group based on sensory tolerance with the goal of maintaining pedaling action and target heart rate over the entire session. At each session, we will record the distance traveled, energy expended, power output, resistance, heart rate and rating of perceived exertion (RPE).
Passive Leg Cycling
PLACEBO COMPARATORPassive leg cycling will involve movement of the participant's legs by the cycle ergometer motor without electrical stimulation. The duration of training will follow the same schedule as the FES cycling condition and the same data will be recorded at each session. The passive cycling condition will include the same exposure with the training facility, the exercise equipment (i.e. RT300 cycles), and the research staff (i.e. social contact and attention) as with the FES cycling condition.
Interventions
FES cycling will use self-adhering surface electrodes (Pals Platinum, Fallbrook, CA) placed over the quadriceps, hamstrings, and gluteal muscle groups to deliver stimulation to the leg muscles.
Passive leg cycling will not involve electrical stimulation
Eligibility Criteria
You may qualify if:
- diagnosis of multiple sclerosis
- relapse free in the past 30 days
- stable course of disease-modifying therapies over the past 6 months
- ability to communicate in English
- willing to come to the University of Ottawa to complete testing and training sessions
- EDSS score 5.0 - 7.0
- asymptomatic based on a physical activity pre-participation screening tool
You may not qualify if:
- presence of any contraindication to FES including epilepsy, a pacemaker, implanted defibrillator, unstable fracture, or pregnancy
- diagnosis of other neurological condition(s)
- participation in FES cycling exercise or other mobility-based exercise rehabilitation program within the past 6 months
- current use of dalfampridine within the past month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ottawalead
- The Ottawa Hospitalcollaborator
- Multiple Sclerosis Society of Canadacollaborator
Study Sites (1)
University of Ottawa
Ottawa, Ontario, K1N 6N5, Canada
Related Publications (3)
Edwards T, Motl RW, Pilutti LA. Cardiorespiratory demand of acute voluntary cycling with functional electrical stimulation in individuals with multiple sclerosis with severe mobility impairment. Appl Physiol Nutr Metab. 2018 Jan;43(1):71-76. doi: 10.1139/apnm-2017-0397. Epub 2017 Sep 7.
PMID: 28881147BACKGROUNDPilutti LA, Motl RW, Edwards TA, Wilund KR. Rationale and design of a randomized controlled clinical trial of functional electrical stimulation cycling in persons with severe multiple sclerosis. Contemp Clin Trials Commun. 2016 May 15;3:147-152. doi: 10.1016/j.conctc.2016.05.005. eCollection 2016 Aug 15.
PMID: 29736463BACKGROUNDEdwards T, Motl RW, Sebastiao E, Pilutti LA. Pilot randomized controlled trial of functional electrical stimulation cycling exercise in people with multiple sclerosis with mobility disability. Mult Scler Relat Disord. 2018 Nov;26:103-111. doi: 10.1016/j.msard.2018.08.020. Epub 2018 Sep 8.
PMID: 30243234BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lara Pilutti, PhD
University of Ottawa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessments will be collected objectively by researchers who are blinded to treatment allocation. Researchers who are involved with delivery of the intervention will be aware of treatment allocation, but will not be involved with data collection, entry or analysis.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 6, 2019
First Posted
May 14, 2019
Study Start
October 16, 2019
Primary Completion
October 28, 2024
Study Completion
October 28, 2024
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share